Top
ERI3 has not been detected as a mutational cancer driver

ERI3
Ensembl id ENSG00000117419
Mutated samples
Coding Sequence 44 (0.6%)
Protein Affecting 16 (0.2%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all ERI3 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Bladder carcinoma No 2 2 2.04
Lung squamous cell carcinoma No 4 2 1.15
Uterine corpus endometrioid carcinoma No 7 2 0.87
Serous ovarian adenocarcinoma No 2 2 0.63
Lung adenocarcinoma No 3 1 0.26
Breast carcinoma No 3 1 0.09
Cutaneous melanoma No 5 1 0.27
Neuroblastoma No 1 1 0.48
Lower grade glioma No 1 1 0.59
Stomach adenocarcinoma No 5 1 0.62
Small cell lung carcinoma No 1 1 1.45
Head and neck squamous cell carcinoma No 5 1 0.27
Hepatocarcinoma No 2 0 0.00
Renal clear cell carcinoma No 1 0 0.00
Thyroid carcinoma No 1 0 0.00
Glioblastoma multiforme No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence